Migräne verstehen – von der klinischen Untersuchung zu standardisierten Behandlungsstrategien

Zusammenfassung

Physiotherapie spielt eine wichtige Rolle beim Management der Migräne, da eine Kombination aus medikamentöser und nicht medikamentöser Therapie am wirksamsten ist. Für eine bestmögliche Therapie ist es essenziell, anhand von Assessments zu verstehen, wie und in welchen Bereichen die Migräne das Leben der Patient*innen am meisten beeinflusst. Dieser Artikel gibt einen narrativen Überblick über die aktuelle Literatur zur Migräne mit Schwerpunkt auf Diagnostik, klinischer Untersuchung, assoziierten Komorbiditäten und standardisierten Beurteilungs- und Behandlungsstrategien

Publication History

Article published online:
14 August 2025

• Literatur

• 1 GBD 2016 Headache Collaborators. Global, regional, and nationalburden of migraine and tension-type headache, 1990–2016: asystematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 954-976
• 2 Steiner TJ, Stovner LJ, Vos T. Migraine is the first cause of disability inunder 50 s: will health politicians now take notice?. J Headache Pain 2018; 19: 10
• 3 World Health Organization (WHO). Migraine and other headache disorders. 2024 Accessed July 07, 2025 at: www.bit.ly/3LQ1Il6
• 4 GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived withdisability for 328 diseases and injuries for 195 countries, 1990–2016: asystematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211-1259
• 5 Headache Classification Committee of the International HeadacheSociety (IHS). The International Classification of Headache Disorders. 3rd edition (ICHD-III). Cephalalgia 2018; 38: 1-211
• 6 Lipton RB, Bigal ME, Diamond M. et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68: 10
• 7 Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119: 355-361
• 8 Thomsen AV, Ashina H, Al-Khazali HM. et al. Clinical features of migraine with aura: a REFORM study. J Headache Pain 2024; 25: 22
• 9 Charles A. The evolution of a migraine attack – a review of the evidence. Headache 2013; 53: 413-419
• 10 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017; 97: 553-622
• 11 Giffin NJ, Ruggiero L, Lipton RB. et al. Premonitory symptoms in migraine: An electronic diary study. Neurology 2003; 60: 935-940
• 12 Kelman L. The postdrome of the acute migraine attack. Cephalalgia 2006; 26: 214-220
• 13 Carvalho IV, Fernandes CS, Damas DP. et al. The migraine postdrome: Clinical characterization, influence of abortive treatment and impact in the quality of life. Clin Neurol Neurosurg 2022; 221: 107408
• 14 Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol 2013; 75: 365-391
• 15 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017; 97: 553-622
• 16 Schulte LH, May A. Of generators, networks and migraine attacks. Curr Opin Neurol 2017; 30: 241-245
• 17 Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: Current concepts and synthesis. Curr Pain Headache Rep 2003; 7: 371-376
• 18 Dodick DW, Silberstein SD. Central sensitization theory of migraine: clinical implications. Headache 2006; 46: S182-S191
• 19 Florencio LL, de Oliveira IV, Lodovichi SS. et al. Cervical muscular endurance performance in women with and without migraine. J Orthop Sports Phys Ther 2019; 49: 330-336
• 20 Bevilaqua-Grossi D, Pinheiro-Araujo CF, Carvalho GF. et al. Neck pain repercussions in migraine – The role of physiotherapy. Musculoskelet Sci Pract 2023; 66: 102786
• 21 Radat F. What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics. Rev Neurol (Paris) 2021; 177: 821-826
• 22 Calhoun AH, Ford S, Pruitt AP. et al. The point prevalence of dizziness or vertigo in migraine and factors that influence presentation. Headache 2011; 51: 1388-1392
• 23 Carvalho GF, Vianna-Bell FH, Florencio LL. et al. Presence of vestibular symptoms and related disability in migraine with and without aura and chronic migraine. Cephalalgia 2019; 39: 29-37
• 24 Carvalho GF, Luedtke K, Bevilaqua-Grossi D. Balance disorders and migraine. Musculoskeletal Sci Pract 2023; 66: 102783
• 25 Carvalho GF, Schwarz A, Szikszay TM. et al. Physical therapy and migraine: musculoskeletal and balance dysfunctions and their relevance for clinical practice. Braz J Phys Ther 2020; 24: 306-317
• 26 Ashina S, Bendtsen L, Lyngberg AC. et al. Prevalence of neck pain in migraine and tension-type headache: A population study. Cephalalgia 2015; 35: 211-219
• 27 Florencio LL, Chaves TC, Carvalho GF. et al. Neck pain disability is related to the frequency of migraine attacks: a cross-sectional study. Headache 2014; 54: 1203-1210 Epub 2014 May 26
• 28 Luedtke K, Starke W, May A. Musculoskeletal dysfunction in migraine patients. Cephalalgia 2018; 38: 865-875
• 29 Watson DH, Drummond PD. Head pain referral during examination of the neck in migraine and tension-type headache. Headache 2012; 52: 1226-1235
• 30 Florencio LL, de Oliveira AS, Carvalho GF. et al. Cervical muscle strength and muscle co-activation during isometric contractions in patients with migraine: a cross-sectional study. Headache 2015; 55: 1312-1322
• 31 Tolentino GA, Bevilaqua-Grossi D, Carvalho GF. et al. Relationship between headaches and neck pain characteristics with neck muscle strength. J Manipulative Physiol Ther 2018; 41: 650-657
• 32 Kurth T, Schürks M, Logroscino G. et al. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008; 337: a636
• 33 Lee MJ, Lee C, Chung C-S. The migraine-stroke connection. J Stroke 2016; 18: 146-156
• 34 Alqaqa A. The Association of Cardiovascular Disease and Migraine: Review. J Clini Exp Cardiol 2016; 7: 465
• 35 Saeed A, Rana KF, Warriach ZI. et al. Association of migraine and ischemic heart disease: a review. Cureus 2019; 11: e5719
• 36 Smitherman TA, Maizels M, Penzien DB. Headache chronification: Screening and behavioral management of comorbid depressive and anxiety disorders. Headache 2008; 48: 45-50
• 37 Buse DC, Silberstein SD, Manack AN. et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol 2013; 260: 1960-1969
• 38 Lipton RB, Hamelsky SW, Kolodner KB. et al. Migraine, quality of life, and depression: a population-based case-control study. Neurology 2000; 55: 629-635
• 39 Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11-23
• 40 Benatto MT, Bevilaqua-Grossi D, Carvalho GF. et al. Kinesiophobia Is Associated with Migraine. Pain Med 2019; 20: 846-851
• 41 Aamodt AH, Stovner LJ, Hagen K. et al. Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study. Cephalalgia 2008; 28: 144-151
• 42 Arzani M, Jahromi SR, Ghorbani Z. et al. Gut-brain axis and migraine headache: a comprehensive review. J Headache Pain 2020; 21: 15
• 43 McGill AT. Causes of metabolic syndrome and obesity-related co-morbidities. Part 1: a composite unifying theory review of human-specific co-adaptations to brain energy consumption. Arch Public Health 2014; 72: 30
• 44 McCarthy LH, Bigal ME, Katz M. et al. Chronic pain and obesity in elderly people: results from the Einstein aging study. J Am Geriatr Soc 2009; 57: 15-19
• 45 Pavlovic JM, Vieira JR, Lipton RB. et al. Association Between Obesity andMigraine in Women. Curr Pain Headache Rep 2017; 21: 41
• 46 Ford ES, Li C, Pearson WS. et al. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 2008; 28: 1270-1276
• 47 Mattsson P. Migraine headache and obesity in women aged 40–74 years: a population-based study. Cephalalgia 2007; 27: 877-880
• 48 Keith SW, Wang C, Fontaine KR. et al. BMI and headache among women: results from 11 epidemiologic datasets. Obesity (Silver Spring) 2008; 16: 377-383
• 49 Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006; 66: 545-550
• 50 Bigal ME, Lipton RB. Putative mechanisms of the relationship between obesity and migraine progression. Curr Pain Headache Rep 2008; 12: 207-212
• 51 Cavestro C, Ferrero M. Migraine in Systemic Autoimmune Diseases. Endocr Metab Immune Disord Drug Targets 2018; 18: 124-134
• 52 Do TP, Remmers A, Schytz HW. et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology 2019; 92: 134-144
• 53 Eigenbrodt AK, Ashina H, Khan S. et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol 2021; 17: 501-514
• 54 Luedtke K, Boissonnault W, Caspersen N. et al. International consensuson the most useful physical examination tests used by physiotherapists for patients with headache: A Delphi study. Man Ther 2016; 23: 17-24
• 55 Burch RC, Loder S, Loder E. et al. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache 2015; 55: 21-34
• 56 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev 2017; 97: 553-622
• 57 Silberstein SD, Tfelt-Hansen P, Dodick DW. et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008; 28: 484-495
• 58 Hoffmann J, Recober A. Migraine and triggers: post hoc ergo propter hoc?. Curr Pain Headache Rep 2013; 17: 370
• 59 Buse DC, Scher AI, Dodick DW. et al. Impact of migraine on the family: Perspectives of people with migraine and their spouse/domestic partner in the CaMEO study. Mayo Clin Prc 2016; 91: 596-611
• 60 Stokes M, Becker WJ, Lipton RB. et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: Results from the International Burden of Migraine Study (IBMS). Headache 2011; 51: 1058-1077
• 61 Steiner TJ, Terwindt GM, Katsarava Z. et al. Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process. Cephalalgia 2022; 42: 1387-1396
• 62 Vincent M, Viktrup L, Nicholson RA. et al. The not so hidden impact of interictal burden in migraine: A narrative review. Front Neurol 2022; 13: 1032103
• 63 Leonardi M, Raggi A, Bussone G. et al. Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 2010; 50: 1576-1586
• 64 Mokkink LB, Terwee CB, Patrick DL. et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539-549
• 65 Luedtke K, Basener A, Bedei S. et al. Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study. BMJ Open 2020; 10: e029855
• 66 Minen MT, Begasse De Dhaem O, Kroon Van Diest A. et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 2016; 87: 741-749
• 67 Louter MA, Pijpers JA, Wardenaar KJ. et al. Symptom dimensions of affective disorders in migraine patients. J Psychosom Res 2015; 79: 458-463
• 68 Spitzer RL, Kroenke K, Williams JB. et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097
• 69 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613
• 70 Bagley CL, Rendas-Baum R, Maglinte GA. et al. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache 2012; 52: 409-421
• 71 Holroyd KA, Malinoski P, Davis MK. et al. The three dimensions of headache impact: Pain, disability and affective distress. Pain 1999; 83: 571-578
• 72 Usai S, Grazzi L, D’Amico D. et al. Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy. Neurol Sci 2008; 29: 176-178
• 73 Stewart WF, Lipton RB, Dowson AJ. et al. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology 2001; 56: S20-S28
• 74 Carvalho GF, Luedtke K, Braun T. Minimal important change and responsiveness of the Migraine Disability Assessment Score (MIDAS) Questionnaire. J Headache Pain 2021; 22: 126
• 75 Kosinski M, Bayliss MS, Bjorner JB. et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003; 12: 963-974
• 76 Pradela J, Bevilaqua-Grossi D, Chaves TC. et al. Measurement properties of the Headache Impact Test (HIT-6™ Brazil) in primary and secondary headaches. Headache 2021; 61: 527-535
• 77 Ashina M, Buse DC, Ashina H. et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet 2021; 397: 1505-1518
• 78 Haghdoost F, Puledda F, Garcia-Azorin D. et al. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia 2023; 43: 3331024231159366
• 79 Herd CP, Tomlinson CL, Rick C. et al. Botulinum toxins for the prevention of migraine in adults. Cochrane Database Syst Rev 2018; 6: CD011616
• 80 Luedtke K, Allers A, Schulte LH. Efficacy of interventions used by physiotherapists for patients with headache and migraine – systematic review and meta-analysis. Cephalalgia 2016; 36: 474-492
• 81 Carvalho G, Quinn R, Luedtke K. Migraine patients‘ experiences with and expectations from physiotherapy. Musculoskelet Sci Pract 2023; 66: 102803
• 82 Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain 2022; 23: 134
• 83 Bae JY, Sung HK, Kwon NY. et al. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina (Kaunas) 2021; 58: 44
• 84 Klan T, Gaul C, Liesering-Latta E. et al. Behavioral treatment for migraine prophylaxis in adults: Moderator analysis of a randomized controlled trial. Cephalalgia 2023; 43: 3331024231178237
• 85 Seng EK, Martin PR, Houle TT. Lifestyle factors and migraine. Lancet Neurol 2022; 21: 911-921
• 86 Kropp P, Meyer B, Meyer W. et al. An update on behavioral treatments in migraine – current knowledge and future options. Expert Rev Neurother 2017; 17: 1059-1068
• 87 Puledda F, Shields K. Non-Pharmacological Approaches for Migraine. Neurotherapeutics 2018; 15: 336-345

• Quelle

• Pradela J, Eschke R, Bevilaqua-Grossi D. et al. Migräne verstehen: von der klinischen Untersuchung zu standardisierten Behandlungsstrategien. MSK 2024; 28: 231-240